aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension [Gaviscon]
RxNorm concept 404472, branded drug (sbd). Prescribable name: Gaviscon Extra Strength 254 MG / 237.5 MG in 5 mL Oral Suspension.
- RxCUI
- 404472
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/404472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Gaviscon Extra Strength Liquid (aluminum hydroxide 254 MG / magnesium carbonate 237.5 MG) per 5 ML Oral Suspension
Related concepts
- aluminum hydroxide 50.8 MG/ML (SCDC, consists of)
- magnesium carbonate 47.5 MG/ML (SCDC, consists of)
- aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML [Gaviscon] (SBDC, consists of)
- Oral Suspension (DF, has dose form)
- Gaviscon (BN, has ingredient)
- aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension (SCD, tradename of)
Linked data
NDCs
- 00088117312
- 00135009541
- 00135057401
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 404472 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/404472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 404472. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.